Trial Details

COMPLETED
Basic Information
Clinical ID c1363
Identifier NCT03103412
Trial Title TD-3504 SAD in Healthy Subjects and Subjects With Ulcerative Colitis (UC)
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Active Mild Ulcerative Colitis, Active Moderate Ulcerative Colitis, Healthy Subjects
Interventions DRUG: TD-3504|DRUG: 15N2-tofacitinib|DRUG: Placebo
Participant Information
Sponsor Theravance Biopharma
City Anaheim
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2017-05-04
Primary Completion Date 2017-11-08
Completion Date 2017-11-08